nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—UGT2B7—Epirubicin—sarcoma	0.318	0.573	CbGbCtD
Etodolac—PTGS2—Etoposide—sarcoma	0.129	0.232	CbGbCtD
Etodolac—PTGS1—Etoposide—sarcoma	0.109	0.196	CbGbCtD
Etodolac—PTGS2—periosteum—sarcoma	0.00398	0.0806	CbGeAlD
Etodolac—PTGS2—leg—sarcoma	0.00317	0.0643	CbGeAlD
Etodolac—UGT1A10—liver—sarcoma	0.00296	0.0599	CbGeAlD
Etodolac—PTGS2—hindlimb—sarcoma	0.00283	0.0574	CbGeAlD
Etodolac—PTGS2—cartilage tissue—sarcoma	0.00279	0.0565	CbGeAlD
Etodolac—PTGS2—appendage—sarcoma	0.00243	0.0492	CbGeAlD
Etodolac—ALB—mammary gland—sarcoma	0.00217	0.044	CbGeAlD
Etodolac—UGT1A3—liver—sarcoma	0.00208	0.0422	CbGeAlD
Etodolac—RXRA—liver—sarcoma	0.00176	0.0357	CbGeAlD
Etodolac—PTGS1—endothelium—sarcoma	0.00153	0.0311	CbGeAlD
Etodolac—UGT1A9—liver—sarcoma	0.00148	0.0301	CbGeAlD
Etodolac—PTGS2—endothelium—sarcoma	0.00147	0.0297	CbGeAlD
Etodolac—CYP2C9—mammary gland—sarcoma	0.00135	0.0275	CbGeAlD
Etodolac—UGT2B7—testis—sarcoma	0.00127	0.0257	CbGeAlD
Etodolac—UGT2B7—liver—sarcoma	0.0012	0.0243	CbGeAlD
Etodolac—PTGS2—myometrium—sarcoma	0.000839	0.017	CbGeAlD
Etodolac—CYP2C9—hematopoietic system—sarcoma	0.000825	0.0167	CbGeAlD
Etodolac—PTGS2—embryo—sarcoma	0.000807	0.0164	CbGeAlD
Etodolac—PTGS1—seminal vesicle—sarcoma	0.000793	0.0161	CbGeAlD
Etodolac—PTGS2—seminal vesicle—sarcoma	0.000758	0.0154	CbGeAlD
Etodolac—PTGS1—hematopoietic system—sarcoma	0.000754	0.0153	CbGeAlD
Etodolac—PTGS1—connective tissue—sarcoma	0.000726	0.0147	CbGeAlD
Etodolac—ALB—testis—sarcoma	0.000725	0.0147	CbGeAlD
Etodolac—PTGS2—hematopoietic system—sarcoma	0.00072	0.0146	CbGeAlD
Etodolac—PTGS2—connective tissue—sarcoma	0.000694	0.0141	CbGeAlD
Etodolac—ALB—liver—sarcoma	0.000685	0.0139	CbGeAlD
Etodolac—PTGS1—smooth muscle tissue—sarcoma	0.000664	0.0135	CbGeAlD
Etodolac—PTGS1—skin of body—sarcoma	0.000655	0.0133	CbGeAlD
Etodolac—PTGS2—smooth muscle tissue—sarcoma	0.000634	0.0129	CbGeAlD
Etodolac—PTGS2—skin of body—sarcoma	0.000626	0.0127	CbGeAlD
Etodolac—PTGS1—cardiac atrium—sarcoma	0.000572	0.0116	CbGeAlD
Etodolac—PTGS1—uterus—sarcoma	0.000569	0.0115	CbGeAlD
Etodolac—PTGS2—uterus—sarcoma	0.000544	0.011	CbGeAlD
Etodolac—ALB—lymph node—sarcoma	0.000525	0.0106	CbGeAlD
Etodolac—Hypersensitivity—Dactinomycin—sarcoma	0.000524	0.00132	CcSEcCtD
Etodolac—Gastrointestinal pain—Vincristine—sarcoma	0.00052	0.00131	CcSEcCtD
Etodolac—Gastritis—Epirubicin—sarcoma	0.00052	0.00131	CcSEcCtD
Etodolac—Confusional state—Etoposide—sarcoma	0.000519	0.00131	CcSEcCtD
Etodolac—Anaphylactic shock—Etoposide—sarcoma	0.000515	0.0013	CcSEcCtD
Etodolac—Asthenia—Thiotepa—sarcoma	0.000514	0.0013	CcSEcCtD
Etodolac—Infection—Etoposide—sarcoma	0.000512	0.00129	CcSEcCtD
Etodolac—Abdominal distension—Epirubicin—sarcoma	0.000511	0.00129	CcSEcCtD
Etodolac—Asthenia—Dactinomycin—sarcoma	0.000511	0.00129	CcSEcCtD
Etodolac—Feeling abnormal—Mitoxantrone—sarcoma	0.00051	0.00129	CcSEcCtD
Etodolac—Asthma—Epirubicin—sarcoma	0.000508	0.00128	CcSEcCtD
Etodolac—Pruritus—Thiotepa—sarcoma	0.000507	0.00128	CcSEcCtD
Etodolac—PTGS2—lymphoid tissue—sarcoma	0.000507	0.0103	CbGeAlD
Etodolac—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000506	0.00128	CcSEcCtD
Etodolac—Thrombocytopenia—Etoposide—sarcoma	0.000504	0.00127	CcSEcCtD
Etodolac—Tachycardia—Etoposide—sarcoma	0.000503	0.00127	CcSEcCtD
Etodolac—Eosinophilia—Epirubicin—sarcoma	0.000503	0.00127	CcSEcCtD
Etodolac—Abdominal pain—Vincristine—sarcoma	0.000503	0.00127	CcSEcCtD
Etodolac—Body temperature increased—Vincristine—sarcoma	0.000503	0.00127	CcSEcCtD
Etodolac—PTGS1—tendon—sarcoma	0.000499	0.0101	CbGeAlD
Etodolac—Hyperhidrosis—Etoposide—sarcoma	0.000498	0.00126	CcSEcCtD
Etodolac—Pancreatitis—Epirubicin—sarcoma	0.000498	0.00126	CcSEcCtD
Etodolac—Abdominal pain upper—Doxorubicin—sarcoma	0.000496	0.00125	CcSEcCtD
Etodolac—Urticaria—Mitoxantrone—sarcoma	0.000492	0.00124	CcSEcCtD
Etodolac—Anorexia—Etoposide—sarcoma	0.000491	0.00124	CcSEcCtD
Etodolac—Diarrhoea—Thiotepa—sarcoma	0.000491	0.00124	CcSEcCtD
Etodolac—Abdominal pain—Mitoxantrone—sarcoma	0.000489	0.00124	CcSEcCtD
Etodolac—Body temperature increased—Mitoxantrone—sarcoma	0.000489	0.00124	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000489	0.00124	CcSEcCtD
Etodolac—Bronchitis—Epirubicin—sarcoma	0.000488	0.00123	CcSEcCtD
Etodolac—Diarrhoea—Dactinomycin—sarcoma	0.000487	0.00123	CcSEcCtD
Etodolac—Pancytopenia—Epirubicin—sarcoma	0.000482	0.00122	CcSEcCtD
Etodolac—Hypotension—Etoposide—sarcoma	0.000481	0.00122	CcSEcCtD
Etodolac—Gastritis—Doxorubicin—sarcoma	0.000481	0.00122	CcSEcCtD
Etodolac—PTGS2—tendon—sarcoma	0.000477	0.00966	CbGeAlD
Etodolac—Neutropenia—Epirubicin—sarcoma	0.000475	0.0012	CcSEcCtD
Etodolac—Dysuria—Epirubicin—sarcoma	0.000475	0.0012	CcSEcCtD
Etodolac—Dizziness—Thiotepa—sarcoma	0.000474	0.0012	CcSEcCtD
Etodolac—Abdominal distension—Doxorubicin—sarcoma	0.000473	0.00119	CcSEcCtD
Etodolac—Asthma—Doxorubicin—sarcoma	0.00047	0.00119	CcSEcCtD
Etodolac—Pollakiuria—Epirubicin—sarcoma	0.000469	0.00119	CcSEcCtD
Etodolac—Hypersensitivity—Vincristine—sarcoma	0.000468	0.00118	CcSEcCtD
Etodolac—Eosinophilia—Doxorubicin—sarcoma	0.000465	0.00118	CcSEcCtD
Etodolac—Photosensitivity reaction—Epirubicin—sarcoma	0.000463	0.00117	CcSEcCtD
Etodolac—Paraesthesia—Etoposide—sarcoma	0.000462	0.00117	CcSEcCtD
Etodolac—PTGS2—bone marrow—sarcoma	0.000462	0.00936	CbGeAlD
Etodolac—Pancreatitis—Doxorubicin—sarcoma	0.000461	0.00116	CcSEcCtD
Etodolac—Dyspnoea—Etoposide—sarcoma	0.000459	0.00116	CcSEcCtD
Etodolac—Hyperglycaemia—Epirubicin—sarcoma	0.000458	0.00116	CcSEcCtD
Etodolac—Somnolence—Etoposide—sarcoma	0.000458	0.00116	CcSEcCtD
Etodolac—Hypersensitivity—Mitoxantrone—sarcoma	0.000456	0.00115	CcSEcCtD
Etodolac—Asthenia—Vincristine—sarcoma	0.000456	0.00115	CcSEcCtD
Etodolac—Vomiting—Thiotepa—sarcoma	0.000456	0.00115	CcSEcCtD
Etodolac—Pneumonia—Epirubicin—sarcoma	0.000455	0.00115	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—sarcoma	0.000452	0.00114	CcSEcCtD
Etodolac—Rash—Thiotepa—sarcoma	0.000452	0.00114	CcSEcCtD
Etodolac—Bronchitis—Doxorubicin—sarcoma	0.000452	0.00114	CcSEcCtD
Etodolac—Dermatitis—Thiotepa—sarcoma	0.000452	0.00114	CcSEcCtD
Etodolac—Headache—Thiotepa—sarcoma	0.000449	0.00113	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000449	0.00113	CcSEcCtD
Etodolac—Rash—Dactinomycin—sarcoma	0.000449	0.00113	CcSEcCtD
Etodolac—Decreased appetite—Etoposide—sarcoma	0.000448	0.00113	CcSEcCtD
Etodolac—Pancytopenia—Doxorubicin—sarcoma	0.000446	0.00113	CcSEcCtD
Etodolac—Renal failure—Epirubicin—sarcoma	0.000445	0.00112	CcSEcCtD
Etodolac—Asthenia—Mitoxantrone—sarcoma	0.000444	0.00112	CcSEcCtD
Etodolac—Fatigue—Etoposide—sarcoma	0.000444	0.00112	CcSEcCtD
Etodolac—Stomatitis—Epirubicin—sarcoma	0.000441	0.00111	CcSEcCtD
Etodolac—Jaundice—Epirubicin—sarcoma	0.000441	0.00111	CcSEcCtD
Etodolac—Pain—Etoposide—sarcoma	0.00044	0.00111	CcSEcCtD
Etodolac—Constipation—Etoposide—sarcoma	0.00044	0.00111	CcSEcCtD
Etodolac—Conjunctivitis—Epirubicin—sarcoma	0.00044	0.00111	CcSEcCtD
Etodolac—Dysuria—Doxorubicin—sarcoma	0.000439	0.00111	CcSEcCtD
Etodolac—Neutropenia—Doxorubicin—sarcoma	0.000439	0.00111	CcSEcCtD
Etodolac—Diarrhoea—Vincristine—sarcoma	0.000435	0.0011	CcSEcCtD
Etodolac—Sweating—Epirubicin—sarcoma	0.000434	0.0011	CcSEcCtD
Etodolac—Pollakiuria—Doxorubicin—sarcoma	0.000434	0.0011	CcSEcCtD
Etodolac—Haematuria—Epirubicin—sarcoma	0.000432	0.00109	CcSEcCtD
Etodolac—Photosensitivity reaction—Doxorubicin—sarcoma	0.000429	0.00108	CcSEcCtD
Etodolac—CYP2C9—liver—sarcoma	0.000428	0.00867	CbGeAlD
Etodolac—Nausea—Thiotepa—sarcoma	0.000426	0.00108	CcSEcCtD
Etodolac—Sinusitis—Epirubicin—sarcoma	0.000425	0.00107	CcSEcCtD
Etodolac—Feeling abnormal—Etoposide—sarcoma	0.000424	0.00107	CcSEcCtD
Etodolac—Hyperglycaemia—Doxorubicin—sarcoma	0.000424	0.00107	CcSEcCtD
Etodolac—Diarrhoea—Mitoxantrone—sarcoma	0.000424	0.00107	CcSEcCtD
Etodolac—Nausea—Dactinomycin—sarcoma	0.000423	0.00107	CcSEcCtD
Etodolac—Agranulocytosis—Epirubicin—sarcoma	0.000422	0.00107	CcSEcCtD
Etodolac—Pneumonia—Doxorubicin—sarcoma	0.000421	0.00106	CcSEcCtD
Etodolac—Gastrointestinal pain—Etoposide—sarcoma	0.000421	0.00106	CcSEcCtD
Etodolac—Dizziness—Vincristine—sarcoma	0.00042	0.00106	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000415	0.00105	CcSEcCtD
Etodolac—PTGS1—testis—sarcoma	0.000413	0.00837	CbGeAlD
Etodolac—Renal failure—Doxorubicin—sarcoma	0.000412	0.00104	CcSEcCtD
Etodolac—Urticaria—Etoposide—sarcoma	0.000409	0.00103	CcSEcCtD
Etodolac—Haemoglobin—Epirubicin—sarcoma	0.000408	0.00103	CcSEcCtD
Etodolac—Stomatitis—Doxorubicin—sarcoma	0.000408	0.00103	CcSEcCtD
Etodolac—Jaundice—Doxorubicin—sarcoma	0.000408	0.00103	CcSEcCtD
Etodolac—Rhinitis—Epirubicin—sarcoma	0.000407	0.00103	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—sarcoma	0.000407	0.00103	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—sarcoma	0.000407	0.00103	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—sarcoma	0.000407	0.00103	CcSEcCtD
Etodolac—Hepatitis—Epirubicin—sarcoma	0.000406	0.00103	CcSEcCtD
Etodolac—Haemorrhage—Epirubicin—sarcoma	0.000406	0.00103	CcSEcCtD
Etodolac—Vomiting—Vincristine—sarcoma	0.000404	0.00102	CcSEcCtD
Etodolac—Pharyngitis—Epirubicin—sarcoma	0.000403	0.00102	CcSEcCtD
Etodolac—Sweating—Doxorubicin—sarcoma	0.000402	0.00101	CcSEcCtD
Etodolac—Rash—Vincristine—sarcoma	0.000401	0.00101	CcSEcCtD
Etodolac—Dermatitis—Vincristine—sarcoma	0.000401	0.00101	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—sarcoma	0.000399	0.00101	CcSEcCtD
Etodolac—Headache—Vincristine—sarcoma	0.000398	0.00101	CcSEcCtD
Etodolac—Vomiting—Mitoxantrone—sarcoma	0.000394	0.000995	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—sarcoma	0.000393	0.000993	CcSEcCtD
Etodolac—Visual impairment—Epirubicin—sarcoma	0.000392	0.000989	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—sarcoma	0.000391	0.000988	CcSEcCtD
Etodolac—Rash—Mitoxantrone—sarcoma	0.00039	0.000986	CcSEcCtD
Etodolac—Dermatitis—Mitoxantrone—sarcoma	0.00039	0.000986	CcSEcCtD
Etodolac—Headache—Mitoxantrone—sarcoma	0.000388	0.00098	CcSEcCtD
Etodolac—Erythema multiforme—Epirubicin—sarcoma	0.000384	0.000971	CcSEcCtD
Etodolac—Hypersensitivity—Etoposide—sarcoma	0.000379	0.000959	CcSEcCtD
Etodolac—Tinnitus—Epirubicin—sarcoma	0.000379	0.000957	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—sarcoma	0.000378	0.000955	CcSEcCtD
Etodolac—Nausea—Vincristine—sarcoma	0.000378	0.000954	CcSEcCtD
Etodolac—Flushing—Epirubicin—sarcoma	0.000377	0.000953	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—sarcoma	0.000377	0.000952	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—sarcoma	0.000376	0.00095	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—sarcoma	0.000376	0.00095	CcSEcCtD
Etodolac—PTGS2—liver—sarcoma	0.000373	0.00756	CbGeAlD
Etodolac—Pharyngitis—Doxorubicin—sarcoma	0.000373	0.000943	CcSEcCtD
Etodolac—Asthenia—Etoposide—sarcoma	0.00037	0.000934	CcSEcCtD
Etodolac—Nausea—Mitoxantrone—sarcoma	0.000368	0.000929	CcSEcCtD
Etodolac—Chills—Epirubicin—sarcoma	0.000365	0.000921	CcSEcCtD
Etodolac—Pruritus—Etoposide—sarcoma	0.000364	0.000921	CcSEcCtD
Etodolac—Arrhythmia—Epirubicin—sarcoma	0.000363	0.000917	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—sarcoma	0.000362	0.000916	CcSEcCtD
Etodolac—Alopecia—Epirubicin—sarcoma	0.000359	0.000907	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—sarcoma	0.000356	0.000898	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—sarcoma	0.000352	0.00089	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—sarcoma	0.000351	0.000886	CcSEcCtD
Etodolac—Flushing—Doxorubicin—sarcoma	0.000349	0.000882	CcSEcCtD
Etodolac—Flatulence—Epirubicin—sarcoma	0.000349	0.000881	CcSEcCtD
Etodolac—Tension—Epirubicin—sarcoma	0.000347	0.000877	CcSEcCtD
Etodolac—Dysgeusia—Epirubicin—sarcoma	0.000346	0.000875	CcSEcCtD
Etodolac—Nervousness—Epirubicin—sarcoma	0.000344	0.000868	CcSEcCtD
Etodolac—Dizziness—Etoposide—sarcoma	0.000341	0.000861	CcSEcCtD
Etodolac—Chills—Doxorubicin—sarcoma	0.000337	0.000852	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—sarcoma	0.000336	0.000849	CcSEcCtD
Etodolac—Vision blurred—Epirubicin—sarcoma	0.000333	0.000842	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—sarcoma	0.000332	0.00084	CcSEcCtD
Etodolac—Ill-defined disorder—Epirubicin—sarcoma	0.000328	0.000829	CcSEcCtD
Etodolac—Vomiting—Etoposide—sarcoma	0.000327	0.000827	CcSEcCtD
Etodolac—Anaemia—Epirubicin—sarcoma	0.000327	0.000826	CcSEcCtD
Etodolac—Rash—Etoposide—sarcoma	0.000325	0.000821	CcSEcCtD
Etodolac—Dermatitis—Etoposide—sarcoma	0.000324	0.00082	CcSEcCtD
Etodolac—Headache—Etoposide—sarcoma	0.000323	0.000815	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—sarcoma	0.000323	0.000815	CcSEcCtD
Etodolac—Tension—Doxorubicin—sarcoma	0.000321	0.000812	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—sarcoma	0.000321	0.00081	CcSEcCtD
Etodolac—Malaise—Epirubicin—sarcoma	0.000319	0.000806	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—sarcoma	0.000318	0.000803	CcSEcCtD
Etodolac—Vertigo—Epirubicin—sarcoma	0.000318	0.000803	CcSEcCtD
Etodolac—Syncope—Epirubicin—sarcoma	0.000317	0.000802	CcSEcCtD
Etodolac—Leukopenia—Epirubicin—sarcoma	0.000317	0.0008	CcSEcCtD
Etodolac—Palpitations—Epirubicin—sarcoma	0.000313	0.00079	CcSEcCtD
Etodolac—Loss of consciousness—Epirubicin—sarcoma	0.000311	0.000786	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—sarcoma	0.000308	0.000779	CcSEcCtD
Etodolac—Convulsion—Epirubicin—sarcoma	0.000307	0.000774	CcSEcCtD
Etodolac—Nausea—Etoposide—sarcoma	0.000306	0.000773	CcSEcCtD
Etodolac—Hypertension—Epirubicin—sarcoma	0.000305	0.000772	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—sarcoma	0.000304	0.000767	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—sarcoma	0.000303	0.000764	CcSEcCtD
Etodolac—Arthralgia—Epirubicin—sarcoma	0.000301	0.000761	CcSEcCtD
Etodolac—Myalgia—Epirubicin—sarcoma	0.000301	0.000761	CcSEcCtD
Etodolac—Anxiety—Epirubicin—sarcoma	0.0003	0.000758	CcSEcCtD
Etodolac—PTGS1—lymph node—sarcoma	0.000299	0.00607	CbGeAlD
Etodolac—Discomfort—Epirubicin—sarcoma	0.000298	0.000752	CcSEcCtD
Etodolac—Malaise—Doxorubicin—sarcoma	0.000295	0.000746	CcSEcCtD
Etodolac—Dry mouth—Epirubicin—sarcoma	0.000295	0.000744	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—sarcoma	0.000294	0.000743	CcSEcCtD
Etodolac—Syncope—Doxorubicin—sarcoma	0.000294	0.000742	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—sarcoma	0.000293	0.00074	CcSEcCtD
Etodolac—Confusional state—Epirubicin—sarcoma	0.000291	0.000736	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—sarcoma	0.000289	0.000731	CcSEcCtD
Etodolac—Oedema—Epirubicin—sarcoma	0.000289	0.000729	CcSEcCtD
Etodolac—Anaphylactic shock—Epirubicin—sarcoma	0.000289	0.000729	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—sarcoma	0.000288	0.000727	CcSEcCtD
Etodolac—Infection—Epirubicin—sarcoma	0.000287	0.000725	CcSEcCtD
Etodolac—PTGS2—lymph node—sarcoma	0.000286	0.0058	CbGeAlD
Etodolac—Shock—Epirubicin—sarcoma	0.000284	0.000718	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—sarcoma	0.000284	0.000717	CcSEcCtD
Etodolac—Thrombocytopenia—Epirubicin—sarcoma	0.000283	0.000714	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—sarcoma	0.000283	0.000714	CcSEcCtD
Etodolac—Tachycardia—Epirubicin—sarcoma	0.000282	0.000712	CcSEcCtD
Etodolac—Hyperhidrosis—Epirubicin—sarcoma	0.000279	0.000705	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—sarcoma	0.000279	0.000704	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—sarcoma	0.000279	0.000704	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—sarcoma	0.000278	0.000702	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—sarcoma	0.000275	0.000696	CcSEcCtD
Etodolac—Anorexia—Epirubicin—sarcoma	0.000275	0.000695	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—sarcoma	0.000273	0.000689	CcSEcCtD
Etodolac—Hypotension—Epirubicin—sarcoma	0.00027	0.000682	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—sarcoma	0.000269	0.000681	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—sarcoma	0.000267	0.000675	CcSEcCtD
Etodolac—Oedema—Doxorubicin—sarcoma	0.000267	0.000675	CcSEcCtD
Etodolac—Infection—Doxorubicin—sarcoma	0.000265	0.000671	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000263	0.000665	CcSEcCtD
Etodolac—Shock—Doxorubicin—sarcoma	0.000263	0.000664	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—sarcoma	0.000262	0.000661	CcSEcCtD
Etodolac—Insomnia—Epirubicin—sarcoma	0.000261	0.00066	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—sarcoma	0.000261	0.000659	CcSEcCtD
Etodolac—Paraesthesia—Epirubicin—sarcoma	0.000259	0.000655	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—sarcoma	0.000258	0.000652	CcSEcCtD
Etodolac—Dyspnoea—Epirubicin—sarcoma	0.000257	0.00065	CcSEcCtD
Etodolac—Somnolence—Epirubicin—sarcoma	0.000257	0.000648	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—sarcoma	0.000255	0.000643	CcSEcCtD
Etodolac—Dyspepsia—Epirubicin—sarcoma	0.000254	0.000642	CcSEcCtD
Etodolac—Decreased appetite—Epirubicin—sarcoma	0.000251	0.000634	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—sarcoma	0.00025	0.000631	CcSEcCtD
Etodolac—Fatigue—Epirubicin—sarcoma	0.000249	0.000629	CcSEcCtD
Etodolac—Pain—Epirubicin—sarcoma	0.000247	0.000624	CcSEcCtD
Etodolac—Constipation—Epirubicin—sarcoma	0.000247	0.000624	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000243	0.000615	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—sarcoma	0.000242	0.00061	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—sarcoma	0.00024	0.000606	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—sarcoma	0.000238	0.000602	CcSEcCtD
Etodolac—Feeling abnormal—Epirubicin—sarcoma	0.000238	0.000601	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—sarcoma	0.000237	0.0006	CcSEcCtD
Etodolac—Gastrointestinal pain—Epirubicin—sarcoma	0.000236	0.000597	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—sarcoma	0.000235	0.000594	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—sarcoma	0.000232	0.000587	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—sarcoma	0.00023	0.000582	CcSEcCtD
Etodolac—Urticaria—Epirubicin—sarcoma	0.000229	0.00058	CcSEcCtD
Etodolac—Pain—Doxorubicin—sarcoma	0.000228	0.000577	CcSEcCtD
Etodolac—Constipation—Doxorubicin—sarcoma	0.000228	0.000577	CcSEcCtD
Etodolac—Abdominal pain—Epirubicin—sarcoma	0.000228	0.000577	CcSEcCtD
Etodolac—Body temperature increased—Epirubicin—sarcoma	0.000228	0.000577	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—sarcoma	0.00022	0.000556	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—sarcoma	0.000218	0.000552	CcSEcCtD
Etodolac—Hypersensitivity—Epirubicin—sarcoma	0.000213	0.000537	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—sarcoma	0.000212	0.000536	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—sarcoma	0.000211	0.000534	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—sarcoma	0.000211	0.000534	CcSEcCtD
Etodolac—Asthenia—Epirubicin—sarcoma	0.000207	0.000523	CcSEcCtD
Etodolac—Pruritus—Epirubicin—sarcoma	0.000204	0.000516	CcSEcCtD
Etodolac—Diarrhoea—Epirubicin—sarcoma	0.000198	0.000499	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—sarcoma	0.000197	0.000497	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—sarcoma	0.000192	0.000484	CcSEcCtD
Etodolac—Dizziness—Epirubicin—sarcoma	0.000191	0.000482	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—sarcoma	0.000189	0.000478	CcSEcCtD
Etodolac—Vomiting—Epirubicin—sarcoma	0.000184	0.000464	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—sarcoma	0.000183	0.000462	CcSEcCtD
Etodolac—Rash—Epirubicin—sarcoma	0.000182	0.00046	CcSEcCtD
Etodolac—Dermatitis—Epirubicin—sarcoma	0.000182	0.00046	CcSEcCtD
Etodolac—Headache—Epirubicin—sarcoma	0.000181	0.000457	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—sarcoma	0.000177	0.000446	CcSEcCtD
Etodolac—Nausea—Epirubicin—sarcoma	0.000171	0.000433	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—sarcoma	0.00017	0.000429	CcSEcCtD
Etodolac—Rash—Doxorubicin—sarcoma	0.000168	0.000426	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—sarcoma	0.000168	0.000425	CcSEcCtD
Etodolac—Headache—Doxorubicin—sarcoma	0.000167	0.000423	CcSEcCtD
Etodolac—Nausea—Doxorubicin—sarcoma	0.000159	0.000401	CcSEcCtD
